You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 23, 2024

Claims for Patent: 7,897,850


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 7,897,850
Title:Barley Lipoxygenase 1 Gene, method of selecting barley variety, material of malt alcoholic drinks and process for producing malt alcoholic drink
Abstract: A selection method for barley lipoxygenase-1 deficient barley, comprising a step of distinguishing the barley lipoxygenase-1 deficient barley by whether or not the guanine at the splicing donor site of the 5th intron of the barley lipoxygenase-1 gene is mutated to a different base; and a method for production of malt alcoholic beverages using a material for malt alcoholic beverages derived from barley obtained by the selection method.
Inventor(s): Hirota; Naohiko (Gunma, JP), Kaneko; Takafumi (Gunma, JP), Kuroda; Hisao (Yaizu, JP), Kaneda; Hirotaka (Yaizu, JP), Takoi; Kiyoshi (Yaizu, JP), Takeda; Kazuyoshi (Kurashiki, JP)
Assignee: Sapporo Breweries Limited (Tokyo, JP)
Application Number:10/550,528
Patent Claims:1. An isolated barley lipoxygenase-1 mutant gene, wherein the guanine at the splicing donor site (5'-GT-3') of the 5th intron of the barley lipoxygenase-1 gene is not guanine.

2. The isolated barley lipoxygenase-1 mutant gene according to claim 1, wherein the nucleotide guanine at the splicing donor site is replaced with adenine.

3. A selection method for barley lipoxygenase-1 deficient barley, the method comprising determining the presence or absence of a guanine at the splicing donor site of the 5th intron of the barley lipoxygenase-1 gene, and selecting the barley having an adenine, thymine or cytosine at the splicing donor site.

4. The selection method for barley lipoxygenase-1 deficient barley according to claim 3, comprising selecting the barley having an adenine at the splicing donor site.

5. The selection method for barley lipoxygenase-1 deficient barley according to claim 3 or 4, wherein the determining comprises extracting genomic DNA from a barley sample, amplifying a DNA fragment containing at least the splicing donor site of the 5th intron of the barley lipoxygenase-1 gene from the extracted genomic DNA, and detecting the amplified DNA fragment by cleaving with a restriction enzyme to determine the presence or absence of guanine at the splicing donor of the 5.sup.th intron of the barley lipoxygenase-1 gene.

6. The selection method for barley lipoxygenase-1 deficient barley according to claim 5, wherein the restriction enzyme.

7. A material for malt alcoholic beverages, wherein the material is selected from a group consisting of a seed, a malt, malt extract, barley decomposition product or processed barley derived from barley, comprising the barley lipoxygenase-1 mutant gene-according to claim 1 or 2.

8. A material for malt alcoholic beverages, wherein the material is selected from a group consisting of a seed, a malt, malt extract, barley decomposition product or processed barley derived from barley selected by the selection method according to claim 3.

9. A method for producing malt alcoholic beverages, the method comprising fermenting wort obtained from a seed, a malt, malt extract, barley decomposition product or processed barley derived from barley according to claim 7 or 8.

10. An isolated nucleic acid comprising the nucleotide sequence from position 1 to 1554 as set forth in SEQ ID NO: 10.

11. An isolated nucleic acid comprising the nucleotide sequence as set forth in SEQ ID NO: 11.

12. An isolated nucleic acid comprising the nucleotide sequence of 10 to 60 continuous bases including the 3178th base in the nucleotide sequence as set forth in SEQ ID NO: 11.

13. A method for detecting the presence of lipoxygenase-1 (LOX-1) activity in barley, the method comprising isolating genomic DNA from a barley sample, and detecting the presence or absence of the 3178th base of SEQ ID NO: 11, wherein the presence of the base is an indicator of the presence of LOX-1 activity in the barley.

14. A seed, a malt, malt extract, barley decomposition product or processed barley derived from barley selected by the selection method according to claim 4.

15. A seed, a malt, malt extract, barley decomposition product or processed barley derived from barley selected by the selection method according to claim 5.

16. A seed, a malt, malt extract, barley decomposition product or processed barley derived from barley selected by the selection method according to claim 6.

17. A method for producing malt alcoholic beverages, the method comprising fermenting a seed, a malt, malt extract, barley decomposition product or processed barley derived from barley according to claim 14, 15, or 16.

Details for Patent 7,897,850

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Merck Sharp & Dohme Corp. INTRON A interferon alfa-2b For Injection 103132 06/04/1986 ⤷  Try a Trial 2023-03-25
Merck Sharp & Dohme Corp. INTRON A interferon alfa-2b For Injection 103132 ⤷  Try a Trial 2023-03-25
Merck Sharp & Dohme Corp. INTRON A interferon alfa-2b Injection 103132 ⤷  Try a Trial 2023-03-25
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.